Vitrakvi
List of products in the National Drug Code with proprietary name vitrakvi. Larotrectinib is used to treat cancer. It works by slowing or stopping the growth of cancer cells.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
|---|---|---|---|---|---|---|
| 50419-390 | Vitrakvi | Larotrectinib | Capsule | Oral | Bayer Healthcare Pharmaceuticals Inc. | Human Prescription Drug |
| 50419-391 | Vitrakvi | Larotrectinib | Capsule | Oral | Bayer Healthcare Pharmaceuticals Inc. | Human Prescription Drug |
| 50419-392 | Vitrakvi | Larotrectinib | Solution, Concentrate | Oropharyngeal | Bayer Healthcare Pharmaceuticals Inc. | Human Prescription Drug |
| 50419-393 | Vitrakvi | Larotrectinib | Solution, Concentrate | Oropharyngeal | Bayer Healthcare Pharmaceuticals Inc. | Human Prescription Drug |
| 71777-390 | Vitrakvi | Larotrectinib | Capsule | Oral | Loxo Oncology, Inc. | Human Prescription Drug |
| 71777-391 | Vitrakvi | Larotrectinib | Capsule | Oral | Loxo Oncology, Inc. | Human Prescription Drug |
| 71777-392 | Vitrakvi | Larotrectinib | Solution | Oral | Loxo Oncology, Inc. | Human Prescription Drug |
